BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 25998575)

  • 1. miR-125a-3p targets MTA1 to suppress NSCLC cell proliferation, migration, and invasion.
    Zhang H; Zhu X; Li N; Li D; Sha Z; Zheng X; Wang H
    Acta Biochim Biophys Sin (Shanghai); 2015 Jul; 47(7):496-503. PubMed ID: 25998575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-183 Acts as a Tumor Suppressor in Human Non-Small Cell Lung Cancer by Down-Regulating MTA1.
    Yang CL; Zheng XL; Ye K; Ge H; Sun YN; Lu YF; Fan QX
    Cell Physiol Biochem; 2018; 46(1):93-106. PubMed ID: 29587281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MTA1 promotes the invasion and migration of non-small cell lung cancer cells by downregulating miR-125b.
    Li Y; Chao Y; Fang Y; Wang J; Wang M; Zhang H; Ying M; Zhu X; Wang H
    J Exp Clin Cancer Res; 2013 May; 32(1):33. PubMed ID: 23718732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
    Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C
    J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells.
    Jiang L; Huang Q; Zhang S; Zhang Q; Chang J; Qiu X; Wang E
    BMC Cancer; 2010 Jun; 10():318. PubMed ID: 20569443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
    Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
    J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-5195-3p plays a suppressive role in cell proliferation, migration and invasion by targeting MYO6 in human non-small cell lung cancer.
    Yang Q
    Biosci Biotechnol Biochem; 2019 Feb; 83(2):212-220. PubMed ID: 30387375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MTA1 gene silencing inhibits invasion and alters the microRNA expression profile of human lung cancer cells.
    Zhu X; Zhang X; Wang H; Song Q; Zhang G; Yang L; Geng J; Li X; Yuan Y; Chen L
    Oncol Rep; 2012 Jul; 28(1):218-24. PubMed ID: 22576802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-550a-3p promotes non-small cell lung cancer cell proliferation and metastasis through down-regulating TIMP2.
    Yang JZ; Bian L; Hou JG; Wang HY
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4156-4165. PubMed ID: 30024604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-1915-3p inhibits cell migration and invasion by targeting SET in non-small-cell lung cancer.
    Pan H; Pan Z; Guo F; Meng F; Zu L; Fan Y; Li Y; Li M; Du X; Zhang X; Shao Y; Wei M; Li X; Zhou Q
    BMC Cancer; 2021 Nov; 21(1):1218. PubMed ID: 34774019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA MIR155HG knockdown suppresses cell proliferation, migration and invasion in NSCLC by upregulating TP53INP1 directly targeted by miR-155-3p and miR-155-5p.
    Ren XY; Han YD; Lin Q
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4822-4835. PubMed ID: 32432745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-125a regulates HAS1 and inhibits the proliferation, invasion and metastasis by targeting STAT3 in non-small cell lung cancer cells.
    Huang H; Huang J; Yao J; Li N; Yang Z
    J Cell Biochem; 2020 Jun; 121(5-6):3197-3207. PubMed ID: 31930562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA LINC00342 regulated cell growth and metastasis in non-small cell lung cancer via targeting miR-203a-3p.
    Chen QF; Kong JL; Zou SC; Gao H; Wang F; Qin SM; Wang W
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7408-7418. PubMed ID: 31539128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-126-3p suppresses the growth, migration and invasion of NSCLC via targeting CCR1.
    Liu R; Zhang YS; Zhang S; Cheng ZM; Yu JL; Zhou S; Song J
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):679-689. PubMed ID: 30720175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-320a-3p/ELF3 axis regulates cell metastasis and invasion in non-small cell lung cancer via PI3K/Akt pathway.
    Zhao W; Sun Q; Yu Z; Mao S; Jin Y; Li J; Jiang Z; Zhang Y; Chen M; Chen P; Chen D; Xu H; Ding S; Yu Z
    Gene; 2018 Sep; 670():31-37. PubMed ID: 29803922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-3607-3p suppresses non-small cell lung cancer (NSCLC) by targeting TGFBR1 and CCNE2.
    Gao P; Wang H; Yu J; Zhang J; Yang Z; Liu M; Niu Y; Wei X; Wang W; Li H; Wang Y; Sun G
    PLoS Genet; 2018 Dec; 14(12):e1007790. PubMed ID: 30557355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiRNA-500a-3p inhibits cell proliferation and invasion by targeting lymphocyte antigen 6 complex locus K (LY6K) in human non-small cell lung cancer.
    Liao XH; Xie Z; Guan CN
    Neoplasma; 2018 Sep; 65(5):673-682. PubMed ID: 30249107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiRNA-125a-3p is a negative regulator of the RhoA-actomyosin pathway in A549 cells.
    Huang B; Luo W; Sun L; Zhang Q; Jiang L; Chang J; Qiu X; Wang E
    Int J Oncol; 2013 May; 42(5):1734-42. PubMed ID: 23525486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-16-1-3p targets TWIST1 to inhibit cell proliferation and invasion in NSCLC.
    Feng QQ; Dong ZQ; Zhou Y; Zhang H; Long C
    Bratisl Lek Listy; 2018; 119(1):60-65. PubMed ID: 29405733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.